Back to Agenda
Industry Collaboration 2030: Head, Heart and Gut Perspectives
Session Chair(s)
Sarah McKay Tremethick
Global Program Lead - Product Development Industry Collaborations
Roche, United Kingdom
Industry consortia have emerged as powerful engines of clinical trial innovation and progress. What do industry collaboration models look like in 2030? Do we need to re-imagine our approach for greater impact?
Learning Objective : Recognize the value of industry collaborations, analyze emerging trends and future innovation opportunities; Shift from patient-centric to patient-driven design thinking; Seek out conversations to expand and enable change.
Speaker(s)
Industry Collaboration 2030: Head Perspective
Craig Lipset, MPH
Decentralized Trials & Research Alliance | Buffalo Initiative, United States
Co-Chair
Industry Collaboration 2030: Heart Perspective
Rebecca Vermeulen, RPH
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Industry Collaboration 2030: Gut Perspective
Jeff Smith
Smith and Jones Innovation, United States
The Curator
Have an account?